-
When Jawbone acquired BodyMedia last month, it made a big splash in the health and fitness tracker space: the two companies are both major, visible players in the quick-moving field, and we predicted that the acquisition would make other competitors like Fitbit and Basis nervous, and possibly lead to...
-
San Antonio, Texas-based Airstrip and Camden, NJ-based mVisum recently announced that they had settled the lawsuit AirStrip brought against mVisum in October 2012 for allegedly infringing on AirStrip’s patent for remote monitoring of patient medical data on smartphones. The settlement will see mVisum...
Posted to
News
by
mobihealthnews
on
Tue, Apr 30 2013
Filed under:
Filed under: Uncategorized, AirStrip Technologies, Robert Bosch Healthcare, mobile health lawsuits, Cooley LLP, patent infringement, intellectual property, mVisum, digital health lawsuits, patent lawsuits
-
By Orion Armon, IP Litigation practice group, Cooley LLP
Since 2009, medical device companies obtained permanent injunctions in 80 percent of cases in which courts ruled on post-trial motions for injunctive relief. The medical device injunction win rate was ten percentage points higher than the win rate...
-
By Orion Armon, Intellectual Property Litigation practice group, Cooley LLP
Until now, the mHealth industry has experienced relatively few patent infringement conflicts, and little or no litigation instituted by non-practicing entities. But these trends may be disrupted within the next few years. Companies...
Posted to
News
by
mobihealthnews
on
Tue, Oct 23 2012
Filed under:
Filed under: Uncategorized, AirStrip Technologies, CardioNet, BodyMedia, MedApps, Robert Bosch Healthcare, ExpressMD, Waldo Health, mobile health patents, USPTO, intellectual property, Basis Science, patent infringement lawsuits, Cardiocom, Intellectual Ventures
-
Posted to
News
by
The Doctor Weighs In
on
Wed, Sep 26 2012
Filed under:
Filed under: EHR, Document Management, imaging, electronic health records, Institute for Health Technology Transformation, Protected health information, PHR, HITECH Act, People in healthcare, Health care professionals, Technology in healthcare, Innovation/innovative companies, McKesson, Health care & health policy, Politics & public policy, Epic Systems, Change Management, patent infringement, intellectual property, Meaningful Use requirements, U.S. Court of Appeals, Waco Hoover, pending claims, MMRGlobal, Robert H. Lorsch, online personal health record patent, highly anticipated outcome, IP, granted notice of allowance, healthcare IT vendors, company's IP, "MyChart", online personal health record provider, transmission of personal health records, seamless connection to doctors and hospitals, stakeholders
-
San Antonio-based AirStrip Technologies announced this week that it had secured a US patent in late August that covers its methodology for mobilizing physiologic data to smartphone, tablets, and other devices. AirStrip’s core product has been its mobile patient monitoring platform, which it offers...
Posted to
News
by
mobihealthnews
on
Tue, Sep 11 2012
Filed under:
Filed under: Uncategorized, AirStrip Technologies, AirStripOB, remote patient monitoring, AirStripRPM, real-time vital sign monitor, mobile health patents, USPTO, digital health patents, intellectual property, critical patient data
-
This is something new I have not seen in genomic research to put various patents out on the market for bid. You can read through the press release and see the descriptions for the patents going up for the highest bidder. This is in the area of the lab-on-a-chip area. Wikipedia offers...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Feb 16 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, DNA, Genomics, Pharma, Research and Development, Brokers, Intellectual property, microarray, technologies, auctions, Biochips, ICAP, lab-on-a-chip
-
This is an interesting series of events and if Allscripts did in fact take and use the software from the small company Pegasus, then some licensing revenue should be in order. It may not be at $400 a copy, but at least make some offer and meet with the company. What software is being used...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Feb 25 2010
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, healthcare, Health IT, Patents, Allscripts, Intellectual property, legal cases, bar coding, Pegasus
-
Last December Teva announced they were going to ask so now it looks like the FDA has given the ok to review. Due to lack of whatever you want to call it these days in Congress, there are no provisions where a generic version of a biotech drug (aka biosimilars) can be approved and the drug is viewed...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Feb 2 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, FDA, Generic Drugs, Congress, Merck, Politics, Amgen, Intellectual property, Teva, Drug approvals, drugs discounts, biosimilar
-
A disappointment for Merck and this is not the only patent tied up in the legal system today, Singulair is another one where the patent is being questioned. Merck plans to appeal the case according to the article, ho hum, more legal cases to drive up the cost of the medicine we need. BD ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Jan 26 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Pharma, FDA, Generic Drugs, Merck, Patents, Amgen, Intellectual property, Teva, legal cases
-
I can see both sides of this with the demand for cheaper drugs and the need for the company who developed them to be protected so they can recoup their expenses. We have couple other issues involved here too in the fact that producing a drug due to technology may not take as much time as it did...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Jan 15 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Generic Drugs, Politics, Obama, Patents, Intellectual property, Pricing, healthcare reform, biologic drugs
-
How long is a drug patent going to last? This is a big question here today with Teva and Mylan being able to start marketing the generic version tomorrow. For us the patients, another big saver in the pharma area if you take Prevacid. The difference in this case, the drug dissolves...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Nov 10 2009
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Generic Drugs, Intellectual property, Teva, Takeda, Mylan, patent, Prevacid
-
E-Zassi has rolled out a standalone module of their InnoVision software – the US Regulatory Calculator. This new tool allows a user to generate a report in less than 10 minutes that documents a potential predicate FDA regulation no., product code and the classification & regulatory pathway associated...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Oct 20 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Medical Devices, FDA, Science, Patents, Research and Development, Intellectual property, Web 2.0, collaboration, e-Zassi
-
The battle for intellectual property is building up with the companies in the sequencing business. A few months ago Illumina filed a legal suit. How this will all work out will be interesting to see. I just posted today about another newcomer that intends to drive pricing even down...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Sep 25 2009
Filed under:
Filed under: Medically Related, Technology, personalized medicine, Genomics, healthcare, Biotech, Science, R and D, Intellectual property, Sequencing Machines, Illumina, arrays, Life Technologies
-
Medical devices are getting “smarter”. I have written a few times on this blog about Cambridge Consultants and some of their work, namely the Blue Tooth Inhaler. Not only is the product a delivery device, but it is also data reporting and capable. You can read more about the device...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Sep 8 2009
Filed under:
Filed under: Medically Related, Technology, healthcare, Medical Devices, Pharma, Intellectual property, Study, Cambridge Consultants, data reporting devices, drug delivery, report, inhalants